Latest news with #NathalieBernier

National Post

Bausch + Lomb Announces 2025 Annual Meeting of Shareholders Results

Article content VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO) ('Bausch + Lomb' or the 'Company'), a leading global eye health company dedicated to helping people see better to live better, today announced the election of the 10 directors nominated at its 2025 Annual Meeting of Shareholders (the 'Annual Meeting') held on May 21, 2025. Detailed results of the vote follow: Article content Article content Name For Against Broker Non-Votes Nathalie Bernier 337,617,248 1,924,336 8,383,437 Gary Hu 337,591,706 1,949,878 8,383,437 Brett Icahn 337,474,287 2,067,297 8,383,437 Sarah B. Kavanagh 337,602,211 1,939,373 8,383,437 Karen L. Ling 337,526,114 2,015,470 8,383,437 John A. Paulson 337,650,735 1,890,849 8,383,437 Russel C. Robertson 337,600,880 1,940,704 8,383,437 Thomas W. Ross, Sr. 337,583,018 1,958,566 8,383,437 Brenton L. Saunders 337,592,062 1,949,522 8,383,437 Andrew C. von Eschenbach, M.D. 337,607,276 1,934,308 8,383,437 Article content Shareholders also approved, in a non-binding advisory vote, the compensation of the Company's named executive officers, appointment of PricewaterhouseCoopers LLP to serve as auditor until the close of the Company's 2026 Annual Meeting of Shareholders, and authorization for the board of directors to fix the auditor's remuneration. Article content The final vote tabulation on all matters voted on at the Annual Meeting will be filed with the U.S. Securities and Exchange Commission on a current report on Form 8-K, and such report will be made available on the Company's SEDAR+ profile and on the Company's website at Article content About Bausch + Lomb Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit and connect with us on Facebook, Instagram, LinkedIn, X and YouTube. Article content Article content Article content Article content Article content Contacts Article content Media Contact: Chris Clark (848) 360-1100 Article content Article content Article content